Диссертация (1140070), страница 29
Текст из файла (страница 29)
2012 Nov; 35(6): 1059-69.38. De Paepe B., Smet J., Lammens M., Seneca S., Martin JJ., De Bkeecjer J. et al.Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle frompatients with mitochondrial DNA encoded tRNA gene defects. J Clin Pathol. 2009; 62(2): 172-6.39. De Paepe B., De Bleecker J.L., Van Coster R. Histochemical Methods for the Diagnosis ofMitochondrial Diseases. Curr Protoc Hum Genet. 2009a Oct; Chapter 19: Unit19.2.40. DiMauro S., Hirano M., Kaufmann P., Tanji K., Sano M., Shungu DC et al. Clinical featuresand genetics of myoclonic epilepsy with ragged red fibers. Adv Neurol. 2002; 89: 217-29.41.
Dirmeier, R. et al. (2004) Measurement of oxidative stress in cells exposed to hypoxia andother changes in oxygen concentration. Methods Enzymol. 381, 589-603.42. Dowling J.J., Arbogast S., Hur J. et al. Oxidative stress and successful antioxidant treatmentin models of RYR1-related myopathy. Brain 2012; 135: Pt 4: 1115-1127.43. Dubowitz V., Sewry C.
A., Oldfors A. Muscle Biopsy: A Practical Approach, 4th Edition.Saunders Elsevier (2013), 572 pages. P. 453- 479.17344. Durieux A.C., Vignaud A., PrudhonB. et al. A centronuclear myopathy- dynamin 2mutationimpairs skeletal muscle structure and function in mice. Hum Mol Genet 2010; 19: 4820-4836.45. El-Hattab A.W., Scaglia F., Mitochondrial disorders, in: B. Lee, F. Scaglia (Eds.), InbornErrors of Metabolism: From Neonatal Screening to Metabolic Pathways, Oxford University Press,New York, NY, USA 2015, pp. 180-202.46. Engel W.K., Cunningham G.G. Rapid examination of muscle tissue: An improved trichromestain method for fresh frozen biopsy sections // Neurology 1963.
V. 13. P. 919-926.47. Essig D.A. Contractile activity-induced mitochondrial biogenesis in skeletal muscle //Exerc. Sport. Sci Rev. 1996. Vol. 24. P. 289–319.48. Fan X., Heijnen C.J., van der Kooij M.A., Groenendaal F., van Bel F. (2009) The role andregulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxicischemic brain injury. Brain Res Rev 62(1): 99–108. doi: 10. 1016/j.brainresrev.2009.09.006.49. Ferreira R., Vitorino R., Alves R.M., Appell H.J., Powers S.K., Duarte J.A., Amado F.Subsarcolemmal and intermyofibrillar mitochondria proteome differences disclose functionalspecializations in skeletal muscle.
Proteomics. 2010 Sep; 10(17): 3142-54. doi:10.1002/pmic.201000173.50. Finsterer J., Chronic anemia as a manifestation of MELAS syndrome, Rev. Investig. Clin.63 (2011) 100-103.51. Fontanesi F., Soto I.C., Horn D., Barrientos A. Mss51 and Ssc1 facilitate translationalregulation of cytochrome c oxidase biogenesis. Mol Cell Biol. 2010 Jan; 30(1): 245-59.52. Fontanesi F1, Clemente P, Barrientos A. Cox25 teams up with Mss51, Ssc1, and Cox14 toregulate mitochondrial cytochrome c oxidase subunit 1 expression and assembly in Saccharomycescerevisiae. J Biol Chem. 2011 Jan 7; 286(1): 555-66.53.
Fox TD (2012). Mitochondrial protein synthesis, import and assembly. Genetics 192, 1203–1234.54. Gerald Pfeffer & Patrick F. Chinnery (2013) Diagnosis and treatment of mitochondrialmyopathies, Annals of Medicine, 45: 1, 4-16.55. Gineste C., De Winter J.M., Kohl C. et al. In vivo and in vitro investigations ofheterozygous nebulinknock-out mice disclose a mild skeletal muscle phenotype. NeuromuscularDisorders 2013; 23: 357–369.56. Gorman GS, Schaefer AM, Ng Y, Gomez N, Blakely EL, Alston CL, Feeney C, Horvath R,Yu-Wai-Man P, Chinnery PF, Taylor RW, Turnbull DM, McFarland R. Prevalence of nuclear andmitochondrial DNA mutations related to adult mitochondrial disease.
Ann Neurol. 2015 May; 77(5):753-9. doi: 10.1002/ana.24362. Epub 2015 Mar 28.57. Gorman, G. S. et al. Prevalence of nuclear and mtDNA mutations related to adultmitochondrial disease. Ann Neurol 77, 753–759 (2015).58. Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve.1995; 18(Suppl 3): S107-12. doi: 10.1002/mus.880181422.59. Grady J.P., Campbell G., Ratnaike T., Blakely E.L., Falkous G., Nesbitt V., Schaefer A.M.,McNally R.J., Gorman G.S., Taylor R.W., Turnbull D.M., McFarland R. Disease progression inpatients with single, large-scale mitochondrial DNA deletions. Brain. 2014 Feb; 137(Pt 2): 323-34.17460.
Greaves, L.C., Reeve, A.K., Taylor, R.W. & Turnbull, D. M. Mitochondrial DNA anddisease. J Pathol 226, 274–286 (2012). 61. Gruber M, Simon MC (2006) Hypoxia-inducible factors, hypoxia, and tumor angiogenesis.Curr Opin Hematol 13(3): 169–174. doi: 10. 1097/01.moh.0000219663.88409.3562. Grumati P., Coletto L., Sabatelli P. et al. Autophagy is defective in collagen VI musculardystrophies, and its reactivation rescues myofiber degeneration. Nat Med 2010; 16: 1313-1320.63. Grünewald A., Lax N.Z., Rocha M.C., Reeve A.K., Hepplewhite P.D., Rygiel K.A., TaylorR.W., Turnbull D.M.
Quantitative quadruple-label immunofluorescence of mitochondrial andcytoplasmic proteins in single neurons from human midbrain tissue.J Neurosci Methods. 2014 Jul 30;232: 143-9.64. Gurgel-Giannetti J., Zanoteli E., de Castro Concentino E.L., Abath Neto O., Pesquero J.B.,Reed U.C., Vainzof M. Necklace fibers as histopathological marker in a patient with severe form of Xlinked myotubular myopathy. Neuromuscul Disord. 2012 Jun; 22(6): 541-5.65. Hedberg C., Lindberg C., Máthé G., Moslemi A.R., Oldfors A.
Myopathy in a woman andher daughter associated with a novel splice site MTM1 mutation. Neuromuscul Disord. 2012 Mar;22(3): 244-51.66. Herasse M., Parain K., Marty I. et al. Abnormal distribution of calcium- handling proteins:A novel distinctive marker in core myopathies. J Neuropathol Exp Neurol 2007; 66: 57-65.67. Hnia K., Tronchère H., Tomczak K.K. et al.
Myotubularin controls desmin intermediatefilament architecture and mitochondrial dynamics in human and mouse skeletal muscle. J Clin Invest2011; 121: 70-85.68. Jungbluth H., Dowling J.J., Ferreiro A. et al. 182nd ENMC International Workshop: RYR1related myopathies. 15-17 April 2011, Naarden, The Netherlands. Neuromuscular Disorders 2012; 22:453-462.69. Jungbluth H., Sewry C.A., Muntoni F. Core myopathies. Semin Pediatr Neurol 2011; 18:239-249.70.
Kaufmann P., Engelstad K., Wei Y., Kulikova R., Oskoui M., Sproule D.M. et al.. Naturalhistory of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology.2011;77(22): 1965-71. doi: 10.1212/WNL.0b013e31823a0c7f71. Kearns T.P., Sayre G.P. Retinitis pigmentosa, external ophthalmoplegia, and complete heartblock: Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol. 1958; 60: 280–9.72. Kilgore JL, Musch TI, Ross CR.
Regional distribution of HSP70 proteins after myocardialinfarction. Basic Res Cardiol 91: 283–288, 1996.73. Kollberg G., Moslemi A.R., Lindberg C., Holme E., Oldfors A. Mitochondrial myopathyand rhabdomyolysis associated with a novel nonsense mutation in the gene encoding cytochrome coxidase subunit I.J Neuropathol Exp Neurol. 2005 Feb; 64(2): 123-8.74. Komaki H., Hayashi Y.K., Tsuburaya R., Sugie K., Kato M., Nagai T., Imataka G., SuzukiS., Saitoh S., Asahina N., Honke K., Higuchi Y., Sakuma H., Saito Y., Nakagawa E., Sugai K., SasakiM., Nonaka I., Nishino I.Inflammatory changes in infantile-onset LMNA-associatedmyopathy.Neuromuscul Disord.
2011 Aug; 21(8): 563-8.17575. Koob A.O., L. Bruns, C. Prassler, E. Masliah, T. Klopstock, A. Bender. Protein analysisthrough Western blot of cells excised individually from human brain and muscle tissue Anal Biochem,425 (2012), pp. 120-124.76. Kramerova I., Kudryashova E., Wu B., Germain S., Vandenborne K., Romain N., HallerR.G., Verity M.A., Spencer M.J. Mitochondrial abnormalities, energy deficit and oxidative stress arefeatures of calpain 3 deficiency in skeletal muscle.
Hum Mol Genet. 2009 Sep 1; 18(17): 3194-205.77. Kühlbrandt W. Structure and function of mitochondrial membrane protein complexes. BMCBiol. 2015 Oct 29; 13: 89. doi: 10.1186/s12915-015-0201-x.78. Le Borgne F., Guyot S., Logerot M. et al. Exploration of lipid metabolism in relation withplasma membrane properties of Duchenne muscular dystrophy cells: influence of L-carnitine.
PLoSOne 2012; 7: 11: e4934679. Liu N., Bezprozvannaya S., Shelton J.M. et al. Mice lacking microRNA 133a developdynamin2–dependent centronuclear myopathy. J Clin Invest 2011; 121: 3258-3268.80. Liu Y, Liu W, Song XD, Zuo J. Effect of GRP75/mtHSP70/PBP74/mortalin overexpressionon intracellular ATP level, mitochondrial membrane potential and ROS accumulation followingglucose deprivation in PC12 cells. Mol Cell Biochem 268: 45–51, 2005.81.
Lloreta J., Orozco M., Gea J. et al. Selective diaphragmatic mitochondrial abnormalities in apatient with marked air flow obstruction // Ultrastruct. Pathol. 1996. Vol. 20. P. 67—71.82. Lorenzoni P. J., Scola R. H., Kamoi Kay C.S., Silvado C.E.S., Werneck L.C.. When shouldMERRF (myoclonus epilepsy associated with ragged-red fibers) be the diagnosis? Arq. NeuroPsiquiatr. 2014, vol.72, n.10, pp. 803-811. ISSN 0004-282X.83. Lorenzoni P.J., Werneck L.C., Kamoi Kay C.S., Silvado C.E.S. Scola R.H.
When shouldMELAS (Mitochondrial myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) be thediagnosis? Arq Neuropsiquiatr. 2015; 73(11): 959-96784. Lorenzoni PJ, Scola RH, Kay CS, Arndt RC, Freund AA, Bruck I et al MELAS: clinicalfeatures, muscle biopsy and molecular genetics. Arq Neuropsiquiatr. 2009; 67(3A): 668-76.85. Lorenzoni PJ, Scola RH, Kay CS, Arndt RC, Silvado CE, Werneck LC. MERRF: clinicalfeatures, muscle biopsy and molecular genetics in Brazilian patients.
Mitochondrion. 2011; 11(3): 52832. doi: 10.1016/j.mito.2011.01.00386. Mahad D., Ziabreva I., Lassmann H., Turnbull D. Mitochondrial defects in acute multiplesclerosis lesions. Brain. 2008 Jul; 131(Pt 7): 1722-35.87. Mahad D.J., Ziabreva I., Campbell G., Laulund F., Murphy J.L., Reeve A.K., et al.Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J NeurosciMeth, 184 (2009), pp. 310–31988.
Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP et al. Phenotypicheterogeneity of the 8344A.G mtDNA "MERRF" mutation. Neurology. 2013; 80(22): 2049-54.89. Mayr J.A., Haack T.B., Freisinger P., Karall D., Makowski C., Koch J., Feichtinger R.G.,Zimmermann F.A., Rolinski B., Ahting U., Meitinger T., Prokisch H., Sperl W. Spectrum of combinedrespiratory chain defects. J Inherit Metab Dis. 2015 Jul; 38(4): 629-40.90. McFarland R, Taylor RW, Turnbull DM. A neurological perspective on mitochondrialdisease. Lancet Neurol 2010; 9: 829–40.17691. Merlini L., Angelin A., Tiepolo T.
et al. Cyclosporin A corrects mitochondrial dysfunctionand muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 2008; 105:5225-5229.92. Mick D.U., Fox T.D., Rehling P. Inventory control: cytochrome c oxidase assemblyregulates mitochondrial translation.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
